AIFM2 and lung adenocarcinoma: Indeed, in mouse models of lung adenocarcinoma (LUAD), FSP1 loss triggers LPO and suppresses tumor formation, and high FSP1 expression correlates with poorer patient survival, indicating its biological importance in cancer progression [61,62] (Figure 2).